Purdue Pharma partners with MMCAP Infuse to provide low─cost opioid use disorder treatment to correctional facilities ...
Purdue Pharma L.P. (Purdue) announced that the company has partnered with MMCAP Infuse to provide buprenorphine and naloxone tablets CIII (generic Suboxone), a medication for opioid use disorder (MOUD), at low cost to correctional facilities for …